1. Homepage
  2. Equities
  3. Belgium
  4. Euronext Bruxelles
  5. Celyad Oncology SA
  6. News
  7. Analyst Reco.
    CYAD   BE0974260896

CELYAD ONCOLOGY SA

(CYAD)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Analyst Recommendations on CELYAD ONCOLOGY SA
02/28HC Wainwright Downgrades Celyad Oncology Neutral From Buy, Shares Plunge 12% at Midday ..
MT
01/11Wells Fargo Adjusts Celyad Oncology's Price Target to $11 from $20, Keeps Overweight Ra..
MT
2021CELYAD ONCOLOGY : HC Wainwright Adjusts Celyad Oncology's Price Target to $15 From $17, Ma..
MT
2021CELYAD ONCOLOGY : JonesTrading Downgrades Celyad Oncology to Hold from Buy
MT
2020CELYAD ONCOLOGY : HC Wainwright Adjusts Celyad Oncology's Price Target to $18 From $22, Ke..
MT